The paradoxical enrichment of the IL-10 pathway in our study may suggest resistance to IL-10′s anti-inflammatory actions in ME/CFS females, as was shown in individuals with Type 2 diabetes [53]. The gene discussed is IL10; the disease is type 2 diabetes mellitus.